Star Tribune (Minneapolis, MN)

AtriCure CEO to Remain in Minnesota


Mike Carrel, CEO of Cincinnati-based AtriCure for about a year, will open what looks like a shadow headquarters and R&D facility for the atrial fibrillation products company in Minnetonka in March. oThe executive team will be split,o Carrel said in an interview. oI told the board [when hired] that I wasnAEt moving to Cincinnati. ItAEs also important to set up research and development in the Twin Cities where weAEll partner with the University of Minnesota. WeAEre hiring engineering, marketing, a vice president of business development. a ThereAEs a lot of talent in the Twin Cities. WeAEre not moving the whole company here. Manufacturing is well-established there.o AtriCure (ticker: ATRC), has seen its stock price double to nearly $19 per share over the last year, a market value approaching $400 million. …

Log in to your account to read this article – and millions more.